Heat Biologics, Inc. (HTBX) Social Stream



Heat Biologics, Inc. (HTBX): $2.38

0.01 (+0.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HTBX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Heat Biologics Inc (HTBX) Price Targets From Analysts

Use the tables below to see what analysts covering Heat Biologics Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-13 4 $33 $15 $20.8 $3.09 573.14%
2022-01-21 3 $33 $10 $19.8 $3.09 540.78%
2022-03-15 3 $33 $10 $18.2 $3.09 489%
2022-03-18 3 $33 $8 $17.8 $3.09 476.05%

The Trend in the Analyst Price Target


HTBX's average price target has moved down $3 over the prior 64 days.

HTBX reports an average of 524.56% for its upside potential over the past 27 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-07 4 33 15 20.8 6.36 227.04%
2021-12-22 4 33 15 20.8 3.82 444.5%
2022-01-13 3 33 15 20.8 3.09 573.14%
2022-01-21 3 33 10 19.8 2.71 630.63%
2022-03-18 3 33 8 17.8 2.63 576.81%

HTBX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


HTBX's average broker recommendation rating improved by 0 over the prior 26 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HTBX as an investment opportunity.

  • In the context of all US stocks, Heat Biologics Inc's upside potential (average analyst target price relative to current price) is greater than 580.25% of them.
  • In terms of how Heat Biologics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -460.8% of that group.
  • HTBX has a greater number of analysts covering the stock than 68.34% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, Heat Biologics Inc's average analyst price target is higher than 192.86% of them.

Stocks similar to Heat Biologics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HROW, HOWL, and HGEN.

What is the outlook for HTBX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.2089 seconds.